Pricing Log in Create free account
Saturday 17 October 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

262.03 5.90 −2.20%
Market cap
$40.5B
P/E
48.4×
Fwd P/E
34.7×
Dividend yield
—
F-score
8/9
Altman Z
4.39
Beneish M
−2.51
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Illumina, Inc. (ILMN) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Illumina, Inc. (ILMN) trades at a EV/Sales of 9.0×. Over the past ten years it has ranged from 2.7× (April 2025) to 21.6× (February 2021); the current reading is higher than 41% of that period. That is above the Diagnostics & Research industry median of 5.5× and above the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 4.8× (5.42%)
FY2024 5.0× 2.70%
FY2023 4.9× (26.62%)
FY2022 6.7× (46.36%)
FY2021 12.5× (20.33%)
FY2020 15.6× 22.48%
FY2019 12.8× 2.79%
FY2018 12.4× 10.68%
FY2017 11.2× 47.37%
FY2016 7.6× (36.91%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 6.1× 35.92%
Mar 2026 4.5× (5.89%)
Dec 2025 4.8× 38.54%
Sep 2025 3.4× (6.86%)
42 more quarters

Against its own ten years

Low 2.7× High 21.6×
Ten-year median 10.2×
Current reading's percentile 45

EV/Sales against peers

Company EV/Sales
LH Labcorp Holdings Inc. compare 2.2×
DGX Quest Diagnostics Incorporated compare 2.7×
IQV IQVIA Holdings Inc. compare 3.4×
A Agilent Technologies, Inc. compare 6.9×
MTD Mettler-Toledo International, Inc. compare 8.4×
ILMN Illumina, Inc. 9.0×
IDXX IDEXX Laboratories, Inc. compare 9.8×
WAT Waters Corporation compare 10.2×
NTRA Natera, Inc. compare 20.5×
Diagnostics & Research industry median 5.5×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ILMN